Safety and Feasibility of the ELIOS System in POAG Patients

Part of paid clinical trials in Glendale, Arizona.

Sponsor
Elios Vision, Inc.
Study ID
NCT05999006
Status
Recruiting
Apply to this trial

Conditions

  • Glaucoma, Primary Open Angle

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ELIOS Procedure — DEVICE
    Treatment with the ELIOS System

Study Details

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)

Key Dates

Start date
Oct 18, 2023
Status verified
Jun 2025
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026

Study Design

Enrollment
65 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: ELIOS Procedure
    ELIOS Procedure

Primary Outcome Measure

Proportion of subjects who achieve a decrease in mean diurnal IOP (DIOP) from baseline of at least 20% on the same or fewer medications [ Time Frame: 12 Months ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Elios Vision Clinical SiteGlendaleArizona85306-
Elios Vision Clinical SiteLargoFlorida33770-
Elios Vision Clinical SiteRock IslandIllinois61201-
Elios Vision Clinical SiteOklahoma CityOklahoma73112-
Elios Vision Clinical SiteKenoshaWisconsin53142-

Find similar trials in Glendale, AZ

By research site
Elios Vision Clinical Site· Glendale, AZElios Vision Clinical Site· Largo, FLElios Vision Clinical Site· Rock Island, ILElios Vision Clinical Site· Oklahoma City, OKElios Vision Clinical Site· Kenosha, WI

Related Studies